Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo.
暂无分享,去创建一个
D. Tu | W. Parulekar | M. Moore | D. Jonker | C. O'Callaghan | J. Hilton | M. Vickers | E. Powell | T. Asmis | J. Hilton | C. O'Callaghan